CA Patent

CA3101680A1 — Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies

Assigned to Temple Univ School of Medicine · Expires 2019-11-28 · 6y expired

What this patent protects

The present invention features compositions comprising an anti-amyloid antibody and methods of treating microbial infection and treating or preventing microbial biofilms using the composition.

USPTO Abstract

The present invention features compositions comprising an anti-amyloid antibody and methods of treating microbial infection and treating or preventing microbial biofilms using the composition.

Drugs covered by this patent

Patent Metadata

Patent number
CA3101680A1
Jurisdiction
CA
Classification
—
Expires
2019-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Temple Univ School of Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.